Ching Siang Tan | Cancer Biology | Research Excellence Award

 

Research Excellence Award

           Researcher Information
Researcher Ching Siang Tan
Affiliation KPJ Healthcare University
Country Malaysia
Scopus ID 56893025800
Documents 71
Citations 1,356
h-index 18
Subject Area Cancer Biology
Event International Molecular Biologist Awards
ORCID 0000-0002-5069-3314
Google Scholar glKya9IAAAAJ

Ching Siang Tan

KPJ Healthcare University, Malaysia

Ching Siang Tan, whose research activities in Cancer Biology have contributed to scientific understanding through peer-reviewed publications, interdisciplinary collaboration, and internationally indexed research outputs. The information presented follows a neutral, encyclopedic style based on publicly available academic records. The Research Excellence Award recognizes researchers who have demonstrated sustained scholarly productivity, measurable research impact, and meaningful scientific contributions within their respective disciplines. [1]

Abstract

Ching Siang Tan is a Malaysian academic researcher whose work focuses primarily on cancer biology and related biomedical sciences. His research profile includes internationally indexed publications, measurable citation impact, and collaborative scientific activities. With 71 publications, 1,356 citations, and an h-index of 18, his scholarly record reflects continued contributions to cancer research and evidence-based biomedical investigation.[1][2]

Keywords

Cancer Biology, Oncology Research, Biomedical Sciences, Scientific Publications, Citation Analysis, Molecular Medicine, Academic Research, Research Excellence.

Introduction

Cancer biology integrates molecular, cellular, genetic, and clinical research to improve the understanding of cancer initiation, progression, diagnosis, and treatment. Researchers working in this discipline contribute to scientific advancement through laboratory investigations, translational studies, and collaborative research initiatives. Bibliometric indicators such as publication output, citation counts, and the h-index provide objective measures that complement qualitative assessments of scientific achievement.[3]

Research Profile

  • Affiliated with KPJ Healthcare University, Malaysia.
  • Primary research specialization in Cancer Biology.
  • Author of 71 Scopus-indexed scholarly publications.
  • Research has received 1,356 scholarly citations.
  • Current Scopus h-index of 18.

Research Contributions

The scientific work of Ching Siang Tan encompasses investigations in cancer biology, molecular mechanisms of disease, translational biomedical research, and collaborative health sciences. His publications contribute to the growing body of knowledge supporting cancer diagnosis, therapeutic strategies, and biomedical innovation. Research dissemination through peer-reviewed journals has enhanced the accessibility and visibility of his scientific findings within the international research community.[2][4]

Publications

  • 71 peer-reviewed scholarly publications indexed in Scopus.
  • Research articles addressing cancer biology and biomedical sciences.
  • Publications cited by researchers across multiple scientific disciplines.

Research Impact

Citation-based indicators demonstrate sustained scholarly influence and scientific visibility. The combination of publication output, citation performance, and collaborative research activity reflects continuing engagement with internationally recognized research standards and contributes to the advancement of cancer biology.[1][5]

Award Suitability

Based on publicly available bibliometric information, Ching Siang Tan demonstrates characteristics commonly considered during academic award evaluations, including sustained publication activity, measurable citation impact, and continued scientific contributions in cancer biology. Such achievements align with the objectives of international academic recognition programs while remaining subject to independent expert review and evaluation.[3]

Conclusion

The academic profile of Ching Siang Tan reflects sustained engagement in cancer biology research through scholarly publications, international collaboration, and measurable citation performance. His documented research achievements provide evidence of continued contributions to biomedical science and support recognition within academic award programs that value research quality, scientific integrity, and scholarly impact.[1]

References

  1. Elsevier. (n.d.). Scopus author details: Ching Siang Tan, Author ID 56893025800. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=56893025800
  2. Google Scholar. (n.d.). Google Scholar Profile of Ching Siang Tan.
    https://scholar.google.com/citations?hl=en&hl=en&user=glKya9IAAAAJ
  3. Hirsch, J. E. (2005). An index to quantify an individual’s scientific research output.
    https://doi.org/10.1073/pnas.0507655102
  4. National Cancer Institute. (n.d.). Cancer Biology Research Overview.
    https://www.cancer.gov/research
  5. International Molecular Biologist Awards. (n.d.). Official Award Website.
    https://molecularbiologist.org/

 

Yu Chieh Su | Cancer Biology | Best Researcher Award

Dr. Yu Chieh Su | Cancer Biology | Best Researcher Award 

Director, Division of Hematology and Oncology | E-DA Hospital | Taiwan

Dr. Yu-Chieh Su’s research focuses on molecular and translational oncology, emphasizing the mechanisms of liver cancer, head and neck cancer, leukemia, and lymphoma. His work investigates tumor biology, resistance pathways, and biomarker discovery to enhance diagnostic accuracy and therapeutic precision. He integrates molecular profiling with immuno-oncology to design targeted therapies that improve patient outcomes. A leader in applying big-data analytics and electronic medical records to oncology, Dr. Su develops predictive models and personalized treatment frameworks using genomic and clinical data integration. His multidisciplinary research extends into artificial intelligence–driven cancer prognosis, genetic biomarker validation, and the study of metabolic influences such as obesity on cancer progression. Through his leadership in national and institutional research initiatives, he has strengthened Taiwan’s position in precision oncology and data-guided cancer care. His contributions have been widely recognized, as reflected in his impressive research metrics, including 4558 total citations, an h-index of 39, and an i10-index of 102 (Google Scholar), with 3,297 citations, an h-index of162, and an i31-index of 69 (Scopus). These achievements demonstrate Dr. Su’s enduring impact on cancer biology, translational research, and the advancement of evidence-based oncology worldwide.

Featured Publications

Su, Y.-C., et al. Prognostic significance of neutrophil-to-lymphocyte ratio in hepatocellular carcinoma. Frontiers in Oncology. — Cited by 128 articles.

Su, Y.-C., et al. Integrative genomic analysis reveals biomarkers for head and neck cancer. BMC Cancer. — Cited by 94 articles.

Su, Y.-C., et al. Clinical outcomes of hematologic malignancies under novel immunotherapy protocols. Medicine (Baltimore). — Cited by 87 articles.